Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$660K Buy
73,436
+5
+0% +$46 0.01% 838
2026
Q1
$682K Sell
73,431
-1,167
-2% -$11.5K 0.01% 787
2025
Q4
$526K Sell
74,598
-502
-0.7% -$3.16K 0.01% 899
2025
Q3
$429K Buy
75,100
+9,760
+15% +$52.1K 0.01% 1003
2025
Q2
$312K Buy
65,340
+27,810
+74% +$160K ﹤0.01% 1146
2025
Q1
$325K Buy
37,530
+6,800
+22% +$71.3K 0.01% 1048
2024
Q4
$379K Sell
30,730
-337
-1% -$4.71K 0.01% 1056
2024
Q3
$485K Buy
31,067
+2,048
+7% +$33.7K 0.01% 921
2024
Q2
$437K Buy
+29,019
New +$403K 0.01% 877

Other funds holding NEOG

Choreo LLC's NEOG Position: Q2 2026 in Review

Choreo LLC increased its Neogen (NEOG) stake by 0.01% in Q2 2026, buying an estimated $46 and bringing the position to 73,436 shares worth $660K. The position accounts for 0.01% of the portfolio, ranked #838.

Choreo LLC first reported a position in NEOG in Q2 2024 and has held it in 9 quarters since. The position peaked at $682K in Q1 2026. 317 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

  • Choreo LLC held 73,436 shares of Neogen worth $660K as of Q2 2026.
  • Choreo LLC bought 5 Neogen shares in Q2 2026, an estimated $46.
  • Neogen made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #838 holding.
  • Choreo LLC first reported a position in Neogen in Q2 2024 and has held it in 9 quarters since.
  • Choreo LLC's Neogen position peaked at $682K in Q1 2026.
  • 317 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.